These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6303606)

  • 41. Poliovirus vaccine options.
    Zimmerman RK; Spann SJ
    Am Fam Physician; 1999 Jan; 59(1):113-8, 125-6. PubMed ID: 9917578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
    Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
    J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Results of a program successfully combining live and killed polio vaccines.
    Lasch EE; Abed Y; Gerichter CB; Massri ME; Marcus O; Hensher R; Goldblum N
    Isr J Med Sci; 1983 Nov; 19(11):1021-3. PubMed ID: 6662685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Vaccination complications (a case of vaccine-contact-poliomyelitis)].
    Vogel C
    Kinderarztl Prax; 1980 Jun; 48(6):296-9. PubMed ID: 7420869
    [No Abstract]   [Full Text] [Related]  

  • 45. Poliomyelitis vaccines: an appraisal after 25 years.
    Melnick JL
    Compr Ther; 1980 Jan; 6(1):6-14. PubMed ID: 7357844
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunity status to polioviruses among non-European union immigrants in Veneto Region (North-East Italy).
    Trivello R; Ngatchu T; Marin V; Moretti G; Malatesta R; Maini P; Moschen ME; Baldo V; De Marzi L; Majori S; Puppo A; Renzulli G
    Ann Clin Lab Sci; 1996; 26(2):154-9. PubMed ID: 8852425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Re: world wide experience with inactivated poliovirus vaccine.
    Arya SC; Agarwal N
    Vaccine; 2009 Jan; 27(1):1. PubMed ID: 18952133
    [No Abstract]   [Full Text] [Related]  

  • 48. Statement on poliomyelitis vaccination for international travellers (evidence-based medicine recommendations). Committee to Advise on Tropical Medicine and Travel (CATMAT).
    Can Commun Dis Rep; 1995 Aug; 21(16):145-8. PubMed ID: 7581211
    [No Abstract]   [Full Text] [Related]  

  • 49. Polioantibody titres in children aged 7-15 years in London.
    Galbraith NS; Fernandes R
    Lancet; 1969 Oct; 2(7624):792-3. PubMed ID: 4186037
    [No Abstract]   [Full Text] [Related]  

  • 50. Poliovirus circulation among schoolchildren during the early phase of the 1992-1993 poliomyelitis outbreak in The Netherlands.
    Oostvogel PM; Rumke HC; Conyn-Van Spaendonck MA; van der Avoort HG; Leeuwenburg J; van Loon AM
    J Infect Dis; 2001 Dec; 184(11):1451-5. PubMed ID: 11709788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Further development of a new transgenic mouse test for the evaluation of the immunogenicity and protective properties of inactivated poliovirus vaccine.
    Dragunsky EM; Ivanov AP; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
    J Infect Dis; 2006 Sep; 194(6):804-7. PubMed ID: 16941347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progress with inactivated poliovirus vaccines derived from the Sabin strains.
    Doi Y; Abe S; Yamamoto H; Horie H; Ohyama H; Satoh K; Tano Y; Ota Y; Miyazawa M; Wakabayashi K; Hashizume S
    Dev Biol (Basel); 2001; 105():163-9. PubMed ID: 11763324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Change offers children the best of both polio vaccines. Oklahoma State Department of Health and the Centers for Disease Control and Prevention.
    J Okla State Med Assoc; 1997 Apr; 90(4):142-9. PubMed ID: 9143160
    [No Abstract]   [Full Text] [Related]  

  • 54. [Poliomyelitis control program in Brasil: study of immunity levels].
    Bastos NC; De Carvalho Filho ES; Schatzmayr H; Homma A; Chaves J
    Bol Oficina Sanit Panam; 1973 Dec; 75(6):511-22. PubMed ID: 4273161
    [No Abstract]   [Full Text] [Related]  

  • 55. Safety and immunogenicity of a booster dose of inactivated poliovirus vaccine produced in vero-cells.
    Haastrup E; Thierry-Carstensen B; Jensen AM; Stellfeld M; Heilmann C
    Vaccine; 2004 Feb; 22(8):958-62. PubMed ID: 15161072
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Seroimmunity to poliovirus in Poitiers, France.
    Agius G; Ranger S; Baillargeau E; Rouches C; Castets M
    Eur J Clin Microbiol; 1986 Apr; 5(2):171-3. PubMed ID: 3013629
    [No Abstract]   [Full Text] [Related]  

  • 57. Absence of humoral immunity to poliovirus in vaccinated individuals.
    Beuen K; White R; Kobayashi R; Farrell C
    Nebr Med J; 1988 Feb; 73(2):40-4. PubMed ID: 2832773
    [No Abstract]   [Full Text] [Related]  

  • 58. Poliovaccine at school entry.
    Lancet; 1969 Mar; 1(7594):561-2. PubMed ID: 4179845
    [No Abstract]   [Full Text] [Related]  

  • 59. Poliomyelitis: A gap in immunity?
    Reid D; Bell EJ; Grist NR; Wilson TS
    Lancet; 1973 Oct; 2(7834):899-900. PubMed ID: 4126933
    [No Abstract]   [Full Text] [Related]  

  • 60. [Virologic and serologic survey of poliomyelitis carried out in 1969 after revaccination].
    Przesmycki F; Zaleska H
    Przegl Epidemiol; 1971; 25(1):37-44. PubMed ID: 4326051
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.